Drug delivery to the posterior segment of the eye through hydrogel contact lenses

Clinical and Experimental Optometry

Volumn 94, Issue 2, 2011, Pages 212-218

  Schultz, Clyde ^a,b   Breaux, Jason ^c   Schentag, Jerome ^a,d   Morck, Douglas ^b  

^a DirectContact LLC   (United States)

^b UNIVERSITY OF CALGARY   (Canada)

^c Pyxant Labs   (United States)

^d UNIVERSITY AT BUFFALO   (United States)

Author keywords

Contact lens; Drug delivery systems; High performance liquid chromatography; Hydrogels; Mass spectrometry; Passive diffusion transport; Ranibizumab

Indexed keywords

EID: 79951991772     PISSN: 08164622     EISSN: 14440938     Source Type: Journal    
DOI: 10.1111/j.1444-0938.2010.00553.x     Document Type: Article

References (25)

1. Gragoudas ES, Adamis AP, Cunningham ET Jr, Feinsod M, Guyer DR. Pegaptanib for neovascular age-related macular degeneration. N Engl J Med 2004; 351: 2805-2816.
2. Kourlas H, Abrams P. Ranibizumab for the treatment of neovascular age-related macular degeneration: a review. Clin Ther 2007; 29: 1850-1861.
3. Takeda AL, Colquitt J, Clegg AJ, Jones J. Pegaptanib and ranibizumab for neovascular age-related macular degeneration: a systematic review. Br J Ophthalmol 2007; 91: 1177-1182.
4. Geroski DH, Edelhauser HF. Drug delivery for posterior segment eye disease. Invest Ophthalmol Vis Sci 2000; 41: 961-964.
5. Del Amo EM, Urtti A. Current and future ophthalmic drug delivery systems. A shift to the posterior segment. Drug Discov Today 2008; 13: 135-143.
6. Jaffe GJ, Ashton P, Pearson A. Intraocular Drug Delivery. New York: Taylor & Francis, 2006. p 362.
7. Hillery AM, Lloyd AW, Swarbrick J. Drug Delivery and Targeting for Pharmacists and Pharmaceutical Scientists. London: Taylor & Francis, 2001. p 475.
8. Hull DS, Edelhauser HF, Hyndiuk RA. Ocular penetration of prednisolone and the hydrophilic contact lens. Arch Ophthalmol 1974; 92: 413-416.
9. Ali M, Horikawa S, Venkatesh S, Saha J, Hong JW, Byrne ME. Zero-order therapeutic release from imprinted hydrogel contact lenses within in vitro physiological ocular tear flow. J Control Release 2007; 124: 154-162.
10. Hori K, Sotozono C, Hamuro J, Yamasaki K, Kimura Y, Ozeki M, Tabata Y etal. Controlled-release of epidermal growth factor from cationized gelatin hydrogel enhances corneal epithelial wound healing. J Control Release 2007; 118: 169-176.
11. Kapoor Y, Chauhan A. Ophthalmic delivery of cyclosporine A from Brij-97 microemulsion and surfactant-laden p-HEMA hydrogels. Int J Pharm 2008; 361: 222-229.
12. Karlgard CC, Jones LW, Moresoli C. Survey of bandage lens use in North America, October-December 2002. Eye Contact Lens 2004; 30: 25-30.
13. Schultz CL, Poling TR, Mint JO. A medical device/drug delivery system for treatment of glaucoma. Clin Exp Optom 2009; 92: 343-348.
14. Schultz CL, Morck DW. Contact lenses as a drug delivery device for epidermal growth factor in the treatment of ocular wounds. Clin Exp Optom 2010; 93: 61-65.
15. Xinming L, Yingde C, Lloyd AW, Mikhalovsky SV, Sandeman SR, Howel CA, Liewen L. Polymeric hydrogels for novel contact lens-based ophthalmic drug delivery systems: a review. Cont Lens Anterior Eye 2008; 31: 57-64.
16. Schultz CL, Morck DW, McKay SG, Olson ME, Buret A. Lipopolysaccharide induced acute red eye and corneal ulcers. Exp Eye Res 1997; 64: 3-9.
17. Schultz CL, Buret AG, Olson ME, Ceri H, Read RR, Morck DW. Lipopolysaccharide entry in the damaged cornea and specific uptake by polymorphonuclear neutrophils. Infect Immun 2000; 68: 1731-1734.
18. Eglen RM, Reisine T, Roby P, Rouleau N, Illy C, Bosse R, Bielefeld M. The use of AlphaScreen technology in HTS: current status. Curr Chem Genomics 2008; 1: 2-10.
19. Bielefeld-Sevigny M. AlphaLISA immunoassay platform- the 'no-wash' high-throughput alternative to ELISA. Assay Drug Dev Technol 2009; 7: 90-92.
20. Edelman JL, Lutz D, Castro MR. Corticosteroids inhibit VEGF-induced vascular leakage in a rabbit model of blood-retinal and blood-aqueous barrier breakdown. Exp Eye Res 2005; 80: 249-258.
21. Baptist AP, Reddy RC. Inhaled corticosteroids for asthma: are they all the same? J Clin Pharm Ther 2009; 34: 1-12.
22. Jusko WJ, Rose JQ. Monitoring prednisone and prednisolone. Ther Drug Monit 1980; 2: 169-176.
23. Nave R, Fisher R, McCracken N. In vitro metabolism of beclomethasone dipropionate, budesonide, ciclesonide and fluticasone propionate in human lung precision-cut tissue slices. Respir Res 2007; 8: 65.
24. Kaufman PL, Alm A, Adler FH. Adler's Physiology of the Eye: Clinical Application. 10th ed. St Louis, MO: Mosby, 2003. p 876.
25. Ahmed I, Patton TF. Importance of the non-corneal absorption route in topical ophthalmic drug delivery. Invest Ophthalmol Vis Sci 1985; 26: 584-587.